Will Kidney Disease Patients Finally Receive New Drug Class? ...Middle East

Medscape - News
Dapagliflozin became the first SGLT2 inhibitor approved for CKD alone just over 2 years ago, but uptake has lagged. Could a similar label gain for empagliflozin, plus a new recommendation, spark change? Medscape Medical News

Hence then, the article about will kidney disease patients finally receive new drug class was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Will Kidney Disease Patients Finally Receive New Drug Class? )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News